Kendall Billman, M.S., is a pharmacogenomic specialist with a strong background in biology and precision medicine. She earned her Bachelor of Science in Biology from the University of Saint Francis and her Master of Science in Pharmacogenomics from Manchester University. Her research interests include the clinical implementation of pharmacogenomic testing, personalized medicine, and improving healthcare outcomes through genetic-guided therapy.